Canton Strategic Holdings, Inc.

Biotech Red Bank, NJ

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Red Bank, NJ
Street
34 Shrewsbury Ave.
Zip
07701

Offering

Total offering
$1.7M
Amount sold
$1.7M
First sale
Jul 23, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
13

How this filing compares

Ranked #29 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.6× the median.

Other New Jersey filings this week: AUGUREY VENTURES I - SERIES ANDURIL E, AUGUREY VENTURES III - SERIES ANDURIL E, AUGUREY VENTURES QP FUND - SERIES ANDURIL E, AUGUREY VENTURES V - SERIES ANDURIL E, Bergamot Music Fund I LP

Leadership

Mark Wendland — Executive Officer (also: Director)

Jacob Asbury — Executive Officer

Angela Radkowski — Executive Officer

Mark Toomey — Executive Officer

Vincent LoPriore — Director

Also named on: Hepion Pharmaceuticals, Inc.

Sireesh Appajosyula — Director

Also named on: Hepion Pharmaceuticals, Inc.

Clay Kahler — Director

Gary Stetz — Director

Also named on: Hepion Pharmaceuticals, Inc.

Jill Sommers — Director

William Wiley — Director

Filing details

Canton Strategic Holdings, Inc. filed a Form D with the SEC on April 15, 2026.

Other newest Biotech companies

Other newest companies in New Jersey